Mark Stevenson

Board Director, Ingersoll Rand | Supervisory Board Member, QIAGEN N.V. | Board Director (Ultima Genomics, Harbinger Health) | Operating Partner, Fivespan Partners | Former EVP/COO Thermo Fisher Scientific

United States

About

After more than 30 years of operational leadership in the life sciences industry — including as Executive Vice President and Chief Operating Officer at Thermo Fisher Scientific, President/COO of Life Technologies, and Senior Partner at Flagship Pioneering — I now focus primarily on board service and selective advisory/investment activities. I currently serve as a Board Director of Ingersoll Rand, as well as on the Supervisory Board of QIAGEN N.V. and the Boards of Directors of Ultima Genomics and Harbinger Health. These roles allow me to contribute strategic and operational perspective drawn from decades of global scale-up and commercialization experience. I also serve as Operating Partner at Fivespan Partners, a value-oriented investment firm, and through Camillus Life Sciences I make occasional investments in early-stage life sciences and technology companies, particularly those developing enabling tools, diagnostics, or deep tech platforms.

Experience

  • Member of The Supervisory Board at QIAGEN
    Jan 2026 - Present · 6 mos

  • Operating Partner at Fivespan Partners
    Oct 2024 - Present · 1 yr 9 mos

    Fivespan is a concentrated, fundamental value investor in industry-leading public companies. We seek to partner with company leadership on opportunities to unlock enduring value for all stakeholders.

  • Board Member at Ultima Genomics
    Oct 2023 - Present · 2 yrs 9 mos

    Unleashing the power of genomics at scale

  • Senior Advisor at General Atlantic
    Jan 2023 - Present · 3 yrs 6 mos

    Advising investment teams and portfolio companies in the Life Sciences sector

  • Board Member at Harbinger Health
    Sep 2022 - Present · 3 yrs 10 mos

    Pioneering the detection of early cancer and cancer screening